{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:40:58Z","timestamp":1718152858584},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jgyn.2015.09.004","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T21:49:59Z","timestamp":1445723399000},"page":"754-759","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["M\u00e9dicaments prescrits et dispens\u00e9s au cours du troisi\u00e8me trimestre de grossesse\u00a0: quelles pratiques et quels risques\u00a0?"],"prefix":"10.1016","volume":"45","author":[{"given":"G.","family":"Parent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mottet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mairot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Baudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Carel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goguey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Riethmuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Limat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2015.09.004_bib0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacolepidemiol Drug Saf"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0105","unstructured":"Loi no\u00a02011-2012\u00a0du 29\u00a0d\u00e9cembre\u00a02011\u00a0relative au renforcement de la s\u00e9curit\u00e9 sanitaire du m\u00e9dicament et des produits de sant\u00e9."},{"key":"10.1016\/j.jgyn.2015.09.004_bib0110","article-title":"Efemeris\u00a0: une nouvelle base de donn\u00e9es fran\u00e7aise","volume":"23","author":"Damase-Michel","year":"2009","journal-title":"Lett Pharmacol"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0115","series-title":"La prescription m\u00e9dicamenteuse avec contre-indication absolue chez la femme enceinte","author":"Le Grand","year":"2002"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/11589170-000000000-00000","article-title":"Drug prescribing before and during pregnancy in South west France: a retrospective study","volume":"34","author":"Crespin","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","article-title":"Prescription of drugs during pregnancy in France","volume":"356","author":"Lacroix","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0130","first-page":"605","article-title":"Drug prescription for pregnant women in the department of the Loire","volume":"55","author":"Garcia","year":"2000","journal-title":"Therapie"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00228-004-0817-1","article-title":"Drug prescription in pregnancy: analysis of a large statutory sickness fund population","volume":"60","author":"Egen-Lappe","year":"2004","journal-title":"Eur J Clin"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0140","first-page":"77","article-title":"Drug use during pregnancy: survey in 250\u00a0women consulting at a university hospital center","volume":"29","author":"Damase-Michel","year":"2000","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0145","first-page":"43","article-title":"Medications exposure during pregnancy. A study in a university hospital","volume":"48","author":"Berthier","year":"1993","journal-title":"Therapie"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0150","first-page":"32","article-title":"Prescription des m\u00e9dicaments chez la femme enceinte\u00a0: analyse descriptive dans le d\u00e9partement de l\u2019Aube","author":"H\u00e9rique","year":"2001","journal-title":"Rev Med Assurance Mal"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0155","series-title":"Suppl\u00e9mentation au cours de la grossesse","year":"1997"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0160","series-title":"Pharmacovigilance. Lettres aux professionnels de sant\u00e9. Rappel sur la contre-indication des AINS \u00e0 partir du d\u00e9but du 6e\u00a0mois de la grossesse, quelle que soit la voie d\u2019administration","year":"2009"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0165","first-page":"131","article-title":"Non steroidal anti-inflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1067\/S0002-9378(03)00662-8","article-title":"Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study","volume":"189","author":"Abbasi","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2515\/therapie\/2011057","article-title":"Risque n\u00e9onatal des m\u00e9dicaments pris \u00e0 la fin de la grossesse","volume":"66","author":"Autret-Leca","year":"2011","journal-title":"Therapie"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0180","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0185","series-title":"M\u00e9dicaments et grossesse","year":"2011"},{"key":"10.1016\/j.jgyn.2015.09.004_bib0095","unstructured":"Centre de r\u00e9f\u00e9rence sur les agents t\u00e9ratog\u00e8nes. http:\/\/www.lecrat.org\/medicament.php3; 2013."}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231515002446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231515002446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:08:41Z","timestamp":1718150921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231515002446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0368231515002446"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2015.09.004","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9dicaments prescrits et dispens\u00e9s au cours du troisi\u00e8me trimestre de grossesse\u00a0: quelles pratiques et quels risques\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgyn.2015.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}